etesevimab: Clinical Trials

2 trials of etesevimab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2
Phase 21Completed 1

Follow etesevimab: new trials by email Literature Review of etesevimab trials Research Report on etesevimab

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff
Bamlanivimab, Placebo, Etesevimab - COVID-19, SARS-CoV2
Phase 3CompletedEli Lilly and Company11802020-08-022022-02-04
A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness
LY3819253, LY3832479, LY3853113 - COVID-19
Phase 2 / Phase 3CompletedEli Lilly and Company33072020-06-172024-04-11

Conditions studied

COVID-19 (2)

Sponsors

Eli Lilly and Company (2)

Countries

United States (2)

Results publications

PMID 34374951, PMID 34473343, PMID 35713300, PMID 33113295, PMID 33475701, PMID 34081073, PMID 34260849, PMID 34346827, PMID 34718468, PMID 35493124, PMID 37329415, PMID 39230829